Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 4 1Phase 3 1

Status

Completed 3

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Breast 1

Conditions

Breast Neoplasms 4Peripheral Nervous System Diseases 3Pain 3Neurotoxicity Syndromes 1Neoplasms 1Cancer Pain 1Acute Pain 1

Interventions

Acupuncture Therapy 4Paclitaxel 3Exercise 3Duloxetine Hydrochloride 3Surveys and Questionnaires 2Physical Therapy Modalities 2Glutamine 2Acetylcysteine 2ziconotide 1sagopilone 1nabilone 1glutamic acid diethyl ester 1eribulin 1allantoicase 1Yoga 1Vitamin B Complex 1Ultrasonic Therapy 1Trimetazidine 1Thioctic Acid 1Therapeutic Touch 1Tadalafil 1Sugars 1Sodium Chloride 1Sirolimus 1Saline Solution 1Prednisolone 1Pentoxifylline 1Pain Management 1Omeprazole 1Omacor 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Completed × Peripheral Nervous System Diseases × Duloxetine Hydrochloride × Clear all
NCT05510856 2024-11-22

Comparative Clinical Study Evaluating the Possible Efficacy of Duloxetine, Gabapentin and Lacosamide on Oxaliplatin-Induced Peripheral Neuropathy in Cancer Patients

Tanta University

Phase 4 Completed
93 enrolled

Neoplasms, Peripheral Nervous System Diseases

NCT04732455 2022-07-11

TIPN

Alexandria University

Phase NA Completed
60 enrolled
Breast

Breast Neoplasms, Peripheral Nervous System Diseases

NCT00489411 2017-04-26

Duloxetine in Treating Peripheral Neuropathy Caused by Chemotherapy in Patients With Cancer

Alliance for Clinical Trials in Oncology

Phase 3 Completed
231 enrolled 14 charts

Pain, Peripheral Nervous System Diseases, Neurotoxicity Syndromes

Data powered by HemOnc (CC BY 4.0) Colophon âš¡